4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity
暂无分享,去创建一个
G. Bifulco | A. Zampella | S. Fiorucci | M. V. D’Auria | Raffaella Ummarino | A. Mencarelli | C. D’Amore | B. Renga | M. G. Chini | S. Marino | S. Petek | M. Chini | C. D'Amore
[1] M. Trauner,et al. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. , 2006, Molecular pharmaceutics.
[2] G. Bifulco,et al. Solomonamides A and B, new anti-inflammatory peptides from Theonella swinhoei. , 2011, Organic letters.
[3] S. Kliewer,et al. Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.
[4] N. Nakayama,et al. Structures of nine oxygenated 4-methylene sterols from Hachijo marine sponge Theonella swinhoei , 1995, Steroids.
[5] Shigeki Matsunaga,et al. Polytheonamides A and B, highly cytotoxic, linear polypeptides with unprecedented structural features, from the marine sponge, Theonella swinhoei. , 2005, Journal of the American Chemical Society.
[6] Roberto Pellicciari,et al. Structural basis for bile acid binding and activation of the nuclear receptor FXR. , 2003, Molecular cell.
[7] C. Djerassi,et al. Sterols in marine invertebrates. 22. Isolation and structure elucidation of conicasterol and theonellasterol, two new 4-methylene sterols from the Red Sea sponges Theonella conica and Theonella swinhoei , 1981 .
[8] V. Sepe,et al. Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei , 2009 .
[9] D. Borderie,et al. Effects of bile acids on the humoral immune response: a mechanistic approach. , 2001, Life sciences.
[10] Marco Migliorati,et al. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter. , 2011, Biochimica et biophysica acta.
[11] R. Soest. The Indonesian sponge fauna: a status report , 1989 .
[12] K. Lindor,et al. Current concepts in the pathogenesis of primary biliary cirrhosis. , 2005, Annals of hepatology.
[13] Gabriele Costantino,et al. Farnesoid X receptor: from structure to potential clinical applications. , 2005, Journal of medicinal chemistry.
[14] M. K. Harper,et al. Aurantosides G, H, and I: three new tetramic acid glycosides from a Papua New Guinea Theonella swinhoei. , 2005, Journal of natural products.
[15] U. Beuers,et al. Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited , 2002, Hepatology.
[16] Sean Ekins,et al. Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR , 2009, PLoS Comput. Biol..
[17] E. Distrutti,et al. Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells. , 2010, Biochemical pharmacology.
[18] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[19] G. Bifulco,et al. Theonellasterols and conicasterols from Theonella swinhoei. Novel marine natural ligands for human nuclear receptors. , 2011, Journal of medicinal chemistry.
[20] K. Lindor,et al. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis , 2010, Current gastroenterology reports.
[21] M F Sanner,et al. Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.
[22] M. Voiculescu,et al. New therapeutical indications of ursodeoxycholic acid. , 2005, Romanian journal of gastroenterology.
[23] T. Kodama,et al. Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation , 2010, Journal of Pharmacology and Experimental Therapeutics.
[24] S. Arihara,et al. Swinhosterols A−C, 4-Methylene Secosteroids from the Marine Sponge Theonella swinhoei , 1997 .
[25] Malcolm R. Davidson,et al. A Model Analysis of Arterial Oxygen Desaturation during Apnea in Preterm Infants , 2009, PLoS Comput. Biol..
[26] V. Sepe,et al. Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. , 2011, Journal of medicinal chemistry.
[27] P. Crews,et al. A serendipitous discovery of isomotuporin-containing sponge populations of Theonella swinhoei. , 2007, Journal of natural products.
[28] M. Schmuth,et al. Modulation of T Lymphocyte Function by the Pregnane X Receptor , 2010, The Journal of Immunology.
[29] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[30] L. Moore,et al. Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. , 2007, Molecular endocrinology.
[31] Fengchun Zhang,et al. Primary biliary cirrhosis: what do autoantibodies tell us? , 2010, World journal of gastroenterology.
[32] G. Bifulco,et al. Solomonsterols A and B from Theonella swinhoei. The first example of C-24 and C-23 sulfated sterols from a marine source endowed with a PXR agonistic activity. , 2011, Journal of medicinal chemistry.
[33] R. F. Angawi,et al. Dehydroconicasterol and aurantoic acid, a chlorinated polyene derivative, from the Indonesian sponge Theonella swinhoei. , 2009, Journal of Natural Products.
[34] M. Mori,et al. Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease. , 2011, Frontiers in bioscience.
[35] L. Moore,et al. The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.
[36] G. Bifulco,et al. Towards new ligands of nuclear receptors. Discovery of malaitasterol A, an unique bis-secosterol from marine sponge Theonella swinhoei. , 2011, Organic & biomolecular chemistry.
[37] F. Baldelli,et al. Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. , 2011, Mini reviews in medicinal chemistry.
[38] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[39] Giuseppe Bifulco,et al. Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor. , 2011, Journal of medicinal chemistry.
[40] C. Selmi,et al. Infectious Agents and Xenobiotics in the Etiology of Primary Biliary Cirrhosis , 2011, Disease markers.
[41] G. Bifulco,et al. Perthamides C-F, potent human antipsoriatic cyclopeptides , 2011 .
[42] A. Zampella,et al. Swinholide J, a Potent Cytotoxin from the Marine Sponge Theonella swinhoei , 2011, Marine drugs.
[43] A. Burroughs,et al. Meta‐analysis: ursodeoxycholic acid for primary sclerosing cholangitis , 2011, Alimentary pharmacology & therapeutics.
[44] L. Moore,et al. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. , 2003, Biochemistry.
[45] E. Distrutti,et al. Targeting farnesoid X receptor for liver and metabolic disorders. , 2007, Trends in molecular medicine.
[46] F. Baldelli,et al. Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. , 2011, European journal of pharmacology.
[47] L. Goad,et al. The 220 MHz NMR spectra of phytosterols , 1976 .
[48] Y. Yi,et al. Oxygenated 4‐Methylidene Sterols from the South China Sea Sponge Theonella swinhoei , 2010 .
[49] Timothy M Willson,et al. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. , 2002, Endocrine reviews.
[50] E Jenny Heathcote,et al. Orphanet Journal of Rare BioMed Central Review Primary biliary cirrhosis , 2008 .
[51] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[52] A. Mcinnes,et al. Identification of C-24 alkyl epimers of marine sterols by 13C nuclear magnetic resonance spectroscopy , 1978 .
[53] R. Evans,et al. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Hofmann. Cholestatic liver disease: pathophysiology and therapeutic options. , 2002, Liver.
[55] R. Evans,et al. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR) , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] W. Alrefai,et al. Bile Acid Transporters: Structure, Function, Regulation and Pathophysiological Implications , 2007, Pharmaceutical Research.
[57] M. Trauner,et al. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. , 2007, Biochimica et biophysica acta.